Beta-thalassemia is delineated as a bunch of heritable blood disorders characterized by abnormalities within the synthesis of beta chains of hemoglobin. Most defects in hemoglobin arise directly from mutations in the structure of the β-globin sequence (HBB). Recent advances in computational tools have made it possible to study the relationship between genotype and phenotype in many diseases, including β-thalassemia. Due to the high prevalence of β-thalassemia, these analyses have helped to know the molecular basis in a better way. In this direction, a related database, called HbVar, was developed in 2001 by a collective academic effort to provide quality and up-to-date information on genomic variations that lead to hemoglobinopathies and thalassemia. Within present study, the aim was to investigate insertion, substitution, and deletion mutations in HBB collected from HbVar and their effects using the in-silico approach. In this comparative analysis, three sequences, one wild-type and two mutated HBB sequences were studied in the South American region. It was determined that the Brazilian nd-HPFH mutated sequence presents the formation of a beta chain in the protein structure, not being able to align or overlap in the wild-type, which results in the alteration of the function of the protein, and therefore the development of Thalassemia disease.
References
[1]
Weatherall, D.J. (2008) Hemoglobinopathies Worldwide: Present and Future. Current Molecular Medicine, 8, 592-599. https://doi.org/10.2174/156652408786241375
[2]
Warsy, A.S., ElHazmi, M.A., Al Momin, A.K., AlHazmi, A. and Aleem, A. (2013) Extensive Polymorphisms in Saudi Beta Thalassaemia Patients. Biosciences Biotechnology Research Asia, 10, 127-132.
[3]
Weatherall, D.J. and Clegg, J.B. (2001) The Thalassaemia Syndromes. Blackwell Science, Oxford. https://doi.org/10.1002/9780470696705
[4]
Amjad, F., Fatima, T., Fayyaz, T., Khan, M. and Qadeer, M. (2020) Novel Genetic Therapeutic Approaches for Modulating the Severity of β-Thalassemia (Review). Biomedical Reports, 13, 1. https://doi.org/10.3892/br.2020.1355
[5]
Galanello, R. and Origa, R. (2010) Beta-Thalassemia. Orphanet Journal of Rare Diseases, 5, 11. https://doi.org/10.1186/1750-1172-5-11
[6]
Zahed, L. (2001) The Spectrum of Beta-Thalassemia Mutations in the Arab Populations. BioMed Research Internationa, 1, Article ID: 918781.
https://doi.org/10.1155/S1110724301000298
[7]
Qari, M.H., Wali, Y., Albagshi, M.H, Alshahrani, M., Alzahrani, A., Alhijji, I.A., et al. (2013) Regional Consensus Opinion for the Management of Beta Thalassemia Major in the Arabian Gulf Area. Orphanet Journal of Rare Diseases, 8, Article No. 143. https://doi.org/10.1186/1750-1172-8-143
[8]
Giardine, B., van Baal, S., Kaimakis, P., Riemer, C., Miller, W., Samara, M., et al. (2007) HbVar Database of Human Hemoglobin Variants and Thalassemia Mutations: 2007 Update. Human Mutation, 28, 206. https://doi.org/10.1002/humu.9479
[9]
Ekins, S., Mestres, J. and Testa, B. (2007) In Silico Pharmacology for Drug Discovery: Methods for Virtual Ligand Screening and Profiling. British Journal of Pharmacology, 152, 9-20. https://doi.org/10.1038/sj.bjp.0707305
[10]
Sieburg, H.B. (1990) Physiological Studies in Silico. Studies in the Sciences of Complexity, 12, 321-342.
[11]
Danchin, A., Medigue, C., Gascuel, O., Soldano, H. and Henaut, A. (1991) From Data Banks to Data Bases. Research in Microbiology, 142, 913-916.
https://doi.org/10.1016/0923-2508(91)90073-J
[12]
Desmet, F.O., Hamroun, D., Lalande, M., Collod-Béroud, G., Claustres, M. and Béroud, C. (2009) Human Splicing Finder: An Online Bioinformatics Tool to Predict Splicing Signals. Nucleic Acids Research, 37, Article No. e67.
https://doi.org/10.1093/nar/gkp215
[13]
Giardine, B., Borg, J., Viennas, E., Pavlidis, C., Moradkhani, K., Joly, P., Bartsakoulia, M., Riemer, C., Miller, W., Tzimas, G., Wajcman, H., Hardison, R.C. and Patrinos, G.P. (2013) Updates of the HbVar Database of Human Hemoglobin Variants and Thalassemia Mutations. Nucleic Acids Research, 42, D1063-D1069.
https://doi.org/10.1093/nar/gkt911
[14]
Costa, F.F., Zago, M.A., Cheng, G., Nechtman, J.F., Stoming, T.A. and Huisman, T.H. (1990) The Brazilian Type of Nondeletional A Gamma-Fetal Hemoglobin Has a C—G Substitution at Nucleotide-195 of the A Gamma-Globin Gene. Blood, 76, 1896-1897.
[15]
Hojas-Bernal, R., McNab-Martin, P., Fairbanks, V.F., Holmes, M.W., Hoyer, J.D., McCormick, D.J. and Kubik, K.S. (1999) Hb Chile (b28 (B10) Leu → Met): An Unstable Hemoglobin Associated with Chronic Methemoglobinemia and Sulfonamide or Methylene Blue-Induced Hemolytic Anemia. Hemoglobin, 23, 125-134.
https://doi.org/10.3109/03630269908996157
[16]
Schwede, T., Kopp, J., Guex, N. and Peitsch, M.C. (2003) SWISS-MODEL: An Automated Protein Homology-Modeling Server. Nucleic Acids Research, 31, 3381-3385.
https://doi.org/10.1093/nar/gkg520
[17]
Colovos, C. and Yeates, T.O. (1993) Verification of Protein Structures: Patterns of Nonbonded Atomic Interactions. Protein Science, 2, 1511-1519.
https://doi.org/10.1002/pro.5560020916
[18]
Williams, C.J., Headd, J.J., Moriarty, N.W., Prisant, M.G., Videau, L.L., Deis, L.N., Verma, V., Keedy, D.A., Hintze, B.J., Chen, V.B., et al. (2018) MolProbity: More and Better Reference Data for Improved All-Atom Structure Validation. Protein Science, 27, 293-315. https://doi.org/10.1002/pro.3330
[19]
Davis, I.W., Leaver-Fay, A., Chen, V.B., Block, J.N., Kapral, G.J., Wang, X., et al. (2007) MolProbity: All-Atom Contacts and Structure Validation for Proteins and Nucleic Acids. Nucleic Acids Research, 35, W375-W383.
https://doi.org/10.1093/nar/gkm216
[20]
Berendsen, H.J.C, Postma, J.P.M., van Gunsteren, W.F. and Hermans, J. (1981) Interaction Models for Water in Relation to Protein Hydration. In: Pullman, B., Ed., Intermolecular Forces, Springer, Dordrecht, 331-342.
https://doi.org/10.1007/978-94-015-7658-1_21
[21]
Kavanaugh, J.S., Rogers, P.H. and Arnone, A. (1992) High-Resolution X-Ray Study of Deoxy Recombinant Human Hemoglobins Synthesized from. Beta.-Globins Having Mutated Amino Termini. Biochemistry, 31, 8640-8647.
https://doi.org/10.1021/bi00151a034
[22]
Snyder, D.A., Aramini, J.M., Yu, B., Huang, Y.J., Xiao, R., Cort, J.R., Shastry, R., Ma, L.-C., Liu, J., Rost, B., et al. (2012) Solution NMR Structure of the Ribosomal Protein RP-L35Ae from Pyrococcus furiosus. Proteins: Structure, Function, and Bioinformatics, 80, 1901-1906. https://doi.org/10.1002/prot.24071
[23]
Bhavani, B.S., Rajaram, V., Bisht, S., Kaul, P., Prakash, V., Murthy, M.R.N., Rao, N.A. and Savithri, H.S. (2008) Importance of Tyrosine Residues of Bacillus stearothermophilus Serine Hydroxymethyltransferase in Cofactor Binding and L-allo-Thr cleavage. The FEBS Journal, 275, 4606-4619.
https://doi.org/10.1111/j.1742-4658.2008.06603.x
[24]
Kadian Singh, P. and Mistry, K.N. (2016) A Computational Approach to Determine Susceptibility to Cancer by Evaluating the Deleterious Effect of nsSNP in XRCC1 Gene on Binding Interaction of XRCC1 Protein with Ligase III. Gene, 576, 141-149.
https://doi.org/10.1016/j.gene.2015.09.084
[25]
Lettre, G. (2012) The Search for Genetic Modifiers of Disease Severity in the β-Hemoglobinopathies. Cold Spring Harbor Perspectives in Medicine, 2, a015032.
https://doi.org/10.1101/cshperspect.a015032
[26]
Onda, M., Akaishi, J., Asaka, S., Okamoto, J., Miyamoto, S., Mizutani, K., et al. (2005) Decreased Expression of Haemoglobin Beta (HBB) Gene in Anaplastic Thyroid Cancer and Recovory of Its Expression Inhibits Cell Growth. British Journal of Cancer, 92, 2216-2224. https://doi.org/10.1038/sj.bjc.6602634
[27]
Carlice-dos-Reis, T., Viana, J., Moreira, F.C., Cardoso, G.L., Guerreiro, J., Santos, S. and Ribeiro-dos-Santos, Â. (2017) Investigation of Mutations in the HBB Gene Using the 1,000 Genomes Database. PLoS ONE, 12, e0174637.
https://doi.org/10.1371/journal.pone.0174637
